THE Therapeutic Goods Administration (TGA) is warning would-be importers of COVID-19 rapid antigen tests (RATs) that only approved sponsors listed as entered on the Australian Register of Therapeutic Goods (ARTG) or their agents are authorised to bring supplies into the country.
In an update issued this morning the TGA stress that the RATs must be the version manufactured and approved for the Australian market and not a parallel import.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Feb 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Feb 22
